In-Vitro Rapid Diagnostic Tests

Device Applications:

Hospitals and Laboratories

Voluntary Counseling & Testing Programs

Public Health Programs

Mobile Clinics

Pharmacies & Physician Offices

Labor & Delivery

Emergency Departments & First Responders

Occupational Exposures

Military Medical Units

Blood Banks

Immigration Screening & Border Checkpoints

Correctional Facilities & Prisons


MultiMED distributes products in the rapidly growing point-of-care diagnostics (POC) segment of the in vitro diagnostics (IVD) market.  MultiMED’s primary product line is MedMira’s rapid diagnostics products.    Our tightly integrated relationship with MedMira allows multiMED to effectively understand their product distribution goals as well as their product development pipeline to give our clients the best innovative products in the In-Vitro Rapid Diagnostic Test market.

MORE -  with our Multiplo rapid tests for use in labs, at the point-of-care, and everywhere in between

VALUE - with an advanced, patented rapid flow-through technology platform like no other

NOW - with a simple, standardized 1-2-3 procedure delivering instant results

MedMira is a biotechnology company engaged in the development and commercialization of rapid diagnostics and technology platforms for infectious and non-infectious diseases, tropical diseases, sexually transmitted diseases and other chronic health conditions.  The Company is headquartered in Halifax, Nova Scotia, Canada and is listed on the TSX Venture Exchange (TSX-V) under the symbol MIR.  MedMira’s patented rapid flow-through technology platform is the basis for our current line of rapid diagnostics for infectious diseases.


Diagnostic applications based on this technology platform are highly accurate, easy to-use, and produce instant results – a strong advantage over most other rapid diagnostics on the market today.  MedMira’s technology and growing portfolio of diagnostics demonstrate excellence in performance and quality in the highly competitive diagnostics industry.


MedMira’s rapid flow-through technology is a practical and scalable innovation that has the potential to improve the wellbeing of people around the world. It is the core engine behind their world class rapid testing solutions for infectious, sexually transmitted, tropical diseases and other chronic healthcare conditions.


Speed and multiplexing are the hallmarks of MedMira’s technology which has endured the most rigorous medical device approval processes in the world and validated by organizations such as the US Army.  MedMira shares their technology with fellow innovators through collaborations, partnerships, and licensing.

© 2017 multiMED Holdings, a division of MultiCORE International Inc.  all rights reserved.